KRISTIN GOTTRY: Open Payments
NPI 1497494553 · HICKORY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,960 in 118 payments from 25 companies in 2025. Trend: 2023 $499 · 2024 $1,568 · 2025 $1,960
Food & beverage: $1,960
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $498 |
| AstraZeneca Pharmaceuticals LP | 9 | $275 |
| GlaxoSmithKline, LLC. | 7 | $151 |
| Novo Nordisk Inc | 10 | $136 |
| Otsuka America Pharmaceutical, Inc. | 2 | $117 |
| PFIZER INC. | 4 | $89 |
| Lilly USA, LLC | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Amgen Inc. | 3 | $55 |
Products named: VRAYLAR, AIRSUPRA, TRELEGY ELLIPTA, REXULTI, UBRELVY, Ozempic, MAVYRET, QULIPTA.
Industry payments across NC — which companies pay providers there.
